Common use of SEC Reporting Clause in Contracts

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections 16(a) and 16(b) of the Exchange Act to report his transactions in Company common stock for six (6) months following the Termination Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions until the end of such six (6) month period.

Appears in 6 contracts

Samples: Separation Agreement (Intermolecular Inc), Separation Agreement (Intermolecular Inc), Separation Agreement (Intermolecular Inc)

AutoNDA by SimpleDocs

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his Executive’s matching transactions in Company common stock for six (6) months following the Termination Separation Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions involving the common stock of the Company until the end of such six (6) month period.

Appears in 4 contracts

Samples: Separation Agreement (Synlogic, Inc.), Separation Agreement (Mirna Therapeutics, Inc.), Separation Agreement (Synlogic, Inc.)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his transactions in Company common stock for six (6) months following the Termination Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions until the end of such six (6) month period.

Appears in 3 contracts

Samples: Separation Agreement (Bebe Stores, Inc.), Separation Agreement (ViewRay, Inc.), Separation Agreement (ViewRay, Inc.)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his transactions in Company common stock for six (6) six months following the Termination Date. Executive hereby agrees not to undertakeabide by all securities laws pertaining to his trading in the common stock of the Company including, directly or indirectlyas required, seeking advance clearance from the Company for any reportable transactions until the end of such six (6) month periodtrade.

Appears in 2 contracts

Samples: Transition and Separation Agreement (Geron Corp), Transition and Separation Agreement (Geron Corp)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his transactions in Company common stock for the six (6) months month period following the Termination DateJune 1, 2013. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions until the end of such six (6) month 6)-month period.

Appears in 2 contracts

Samples: Transition and Separation Agreement (Codexis Inc), Transition and Separation Agreement (Codexis Inc)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his transactions in Company common stock for six (6) months following the Termination Separation Date. Excluding the exercise of vested stock options, Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions involving the common stock of the Company until the end of such six (6) month period.

Appears in 2 contracts

Samples: Separation Agreement (Mirna Therapeutics, Inc.), Transition and Separation Agreement (Mirna Therapeutics, Inc.)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he Executive will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his or her transactions in Company common stock for six (6) months following the Termination Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions which include, but are not limited to, buying, selling or otherwise disposing of any common stock of the Company held by Executive until the end of such six (6) month period.

Appears in 2 contracts

Samples: Separation Agreement (KalVista Pharmaceuticals, Inc.), Separation Agreement (KalVista Pharmaceuticals, Inc.)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his transactions matching transactions, if any, in Company common stock for six (6) months following the Termination Separation Date. Executive hereby agrees not further acknowledges that any transactions by Executive involving Company securities will remain subject to undertakesecurities laws in all respects, directly or indirectlyincluding, any reportable transactions until without limitation, laws regarding trading on the end basis of such six (6) month periodmaterial nonpublic information.

Appears in 2 contracts

Samples: Transition and Separation Agreement (Nevro Corp), Separation Agreement (Nevro Corp)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his any matching transactions in Company common stock for six (6) months following the Termination Separation Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable matching transactions until the end of such six (6) month period.

Appears in 2 contracts

Samples: Transition and Separation Agreement (ViewRay, Inc.), Transition and Separation Agreement (ViewRay, Inc.)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his transactions in Company common stock for six (6) months following the Termination Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions SV\1750642.3 which include, but are not limited to, buying, selling or otherwise disposing of any common stock of the Company held by Executive until the end of such six (6) month period.

Appears in 1 contract

Samples: Transition and Separation Agreement (Carbylan Therapeutics, Inc.)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his certain transactions in Company common stock for six (6) months following the Termination Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions until the end of such six (6) month period.

Appears in 1 contract

Samples: Separation Agreement (Integrated Device Technology Inc)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he Executive will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his any matching transactions in Company common stock for six (6) months following the Termination Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions until the end of such six (6) month period.

Appears in 1 contract

Samples: Separation Agreement (Unity Biotechnology, Inc.)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he Executive will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his transactions in Company common stock for six (6) months following the Termination Transition Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions until the end of such six (6) six-month period.

Appears in 1 contract

Samples: Transition and Separation Agreement (Calix, Inc)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he Executive will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his any matching transactions in Company common stock for six (6) months following the Termination Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable matching transactions until the end of such six (6) month period.

Appears in 1 contract

Samples: Separation Agreement (CytomX Therapeutics, Inc.)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his transactions matching transactions, if any, in Company common stock for six (6) months following the Termination Effective Date. Executive hereby agrees not further acknowledges that any transactions by Executive involving Company securities will remain subject to undertakesecurities laws in all respects, directly or indirectlyincluding, any reportable transactions until without limitation, laws regarding trading on the end basis of such six (6) month periodmaterial nonpublic information.

Appears in 1 contract

Samples: Transition and Separation Agreement (Achaogen Inc)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he she will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his Executive’s matching transactions in Company common stock for six (6) months following the Termination Separation Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions involving the common stock of the Company until the end of such six (6) month period.

Appears in 1 contract

Samples: Separation Agreement (Mirna Therapeutics, Inc.)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections 16(a) and 16(b) of the Exchange Act to report his certain transactions in Company common stock for six (6) months following the Termination Retirement Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions until the end of such six (6) month period.

Appears in 1 contract

Samples: Separation Agreement (Achaogen Inc)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his transactions transactions, if any, in Company common stock for up to six (6) months following the Termination Datedate Executive ceases to serve as a member of the Board. Executive hereby agrees not further acknowledges that any transactions by Executive involving Company securities will remain subject to undertakesecurities laws in all respects, directly or indirectlyincluding, any reportable transactions until without limitation, laws regarding trading on the end basis of such six (6) month periodmaterial nonpublic information.

Appears in 1 contract

Samples: Transition and Separation Agreement (Codexis, Inc.)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he Executive will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his transactions in Company common stock for six (6) months following the Termination Transition Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions until the end of such six (6) month period.

Appears in 1 contract

Samples: Transition and Separation Agreement (Calix, Inc)

AutoNDA by SimpleDocs

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections 16(a) and 16(b) of the Exchange Act to report his any matching transactions in Company common stock for six (6) months following the Termination Separation Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable matching transactions until the end of such six (6) month period.

Appears in 1 contract

Samples: Separation Agreement (Prothena Corp PLC)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he or she will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his transactions in Company common stock for six (6) months following the Termination Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions which include, but are not limited to, buying, selling or otherwise disposing of any common stock of the Company held by Executive until the end of such six (6) month period.

Appears in 1 contract

Samples: Transition and Separation Agreement (Codexis Inc)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he Executive will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his transactions in Company common stock for six (6) months following the Termination Transition Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions which include, but are not limited to, buying, selling or otherwise disposing of any common stock of the Company held by Executive until the end of such six (6) six-month period.

Appears in 1 contract

Samples: Transition and Separation Agreement (Calix, Inc)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his transactions in Company common stock for the six (6) months month period following the Termination DateNovember 15, 2013. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions until the end of such six (6) month 6)-month period.

Appears in 1 contract

Samples: Transition and Separation Agreement (Codexis Inc)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his certain transactions in Company common stock for six (6) months following the Termination Separation and Retirement Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions until the end of such six (6) month period.

Appears in 1 contract

Samples: Transition and Separation Agreement (Aimmune Therapeutics, Inc.)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his transactions matching transactions, if any, in Company common stock for six (6) months following the Termination Date. Executive hereby agrees not further acknowledges that any transactions by Executive involving Company securities will remain subject to undertakesecurities laws in all respects, directly or indirectlyincluding, any reportable transactions until without limitation, laws regarding trading on the end basis of such six (6) month periodmaterial nonpublic information.

Appears in 1 contract

Samples: Transition and Separation Agreement (Aimmune Therapeutics, Inc.)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he Executive will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his certain Executive’s transactions in Company common stock for six (6) months following the Termination Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions until the end of such six (6) month period.

Appears in 1 contract

Samples: Transition and Separation Agreement (Thoratec Corp)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his any matching transactions in Company common stock for six (6) months following the Termination Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions until the end of such six (6) month period.

Appears in 1 contract

Samples: Separation Agreement (Aimmune Therapeutics, Inc.)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his transactions in Company common stock for six (6) months following the Termination Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions which include, but are not limited to, buying, selling or otherwise disposing of any common stock of the Company held by Executive until the end of such six (6) month period.

Appears in 1 contract

Samples: Separation Agreement (Carbylan Therapeutics, Inc.)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under Sections 16(a) and 16(b) of the Exchange Act to report his any matching transactions in Company common stock for six (6) months following the Termination Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions until the end of such six (6) month period.

Appears in 1 contract

Samples: Separation Agreement (Codexis Inc)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he Executive will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his any matching transactions in Company common stock for six (6) months following the Termination Retirement Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable matching transactions until the end of such six (6) month period.

Appears in 1 contract

Samples: Retirement Agreement (CytomX Therapeutics, Inc.)

SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he Executive will have continuing obligations under Sections Section 16(a) and 16(b) of the Exchange Act to report his any matching transactions in Company common stock for six (6) months following the Termination Date. Executive hereby agrees not to undertake, directly or indirectly, any reportable transactions until the end of such six (6) month period.US-DOCS\110102732.3

Appears in 1 contract

Samples: Separation Agreement (CytomX Therapeutics, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.